BRIEF published on 09/05/2024 at 07:35, 1 year 9 months ago Medincell: Promising advances for injectable Olanzapine Schizophrenia Phase 3 Medincell Olanzapine Teva Pharmaceuticals
PRESS RELEASE published on 09/05/2024 at 07:30, 1 year 9 months ago Inside Information / Other news releases Teva provides update on pivotal Phase 3 of Olanzapine LAI by Medincell. Safety results on track for H2 2024. Potential innovative long-acting antipsychotic treatment Clinical Trials Phase 3 Medincell Teva Olanzapine LAI
BRIEF published on 08/20/2024 at 17:52, 1 year 9 months ago Terms of participation in the Medincell General Meeting Shareholders General Assembly Remote Voting Medincell Videoconference
PRESS RELEASE published on 08/20/2024 at 17:47, 1 year 9 months ago Terms of availability of the preparatory documents for the GM Medincell announces participation terms in the Combined General Meeting on September 12, 2024, including remote voting options, video conference for shareholders, and document availability Shareholders Combined General Meeting Remote Voting Medincell Participation Terms
BRIEF published on 06/28/2024 at 07:35, 1 year 11 months ago H.C. Wainwright & Co. Initiates MedinCell’s Coverage with "Buy" Recommendation FDA Approval BUY Rating Biopharmaceuticals H.C. Wainwright & Co. Medincell
PRESS RELEASE published on 06/28/2024 at 07:30, 1 year 11 months ago Inside Information / Other news releases H.C. Wainwright & Co. initiates coverage of MedinCell with a 'Buy' recommendation at €24 price target, reflecting +80% potential increase. MedinCell achieves milestones with FDA approvals, positive Phase 3 results, and collaboration with AbbVie FDA Approval Coverage Initiation H.C. Wainwright & Co. Medincell Pharmaceutical Sector
BRIEF published on 06/11/2024 at 09:05, 2 years ago Medincell Joins Euronext Tech Leaders Index Innovation Tech Sector Investor Visibility Medincell Euronext Tech Leaders
PRESS RELEASE published on 06/11/2024 at 09:00, 2 years ago Inside Information / Other news releases Medincell joins Euronext Tech Leaders, gaining access to a broad investor base and support services. CEO Christophe Douat highlights the company's growth and tech innovation leadership Tech Sector Financial Strategy Investor Base Medincell Euronext Tech Leaders
BRIEF published on 05/10/2024 at 18:05, 2 years 1 month ago Medincell announces details on capital and voting rights in accordance with regulations Euronext Paris Share Capital Voting Rights Financial Regulation Medincell
BRIEF published on 05/08/2024 at 12:35, 2 years 1 month ago Positive Results for the SOLARIS Phase 3 Trial of Olanzapine Schizophrenia Medincell SOLARIS Olanzapine TEV-'749
Published on 06/17/2026 at 00:35, 6 hours 10 minutes ago INEO Tech Corp. Announces Closing of Private Placement and Debt Settlement
Published on 06/17/2026 at 00:28, 6 hours 17 minutes ago Apex Critical Metals Announces Filing of Technical Report on the Rift Rare Earth Project
Published on 06/17/2026 at 00:10, 6 hours 35 minutes ago Panther Minerals Announces Brokered Private Placement of up to $3,000,000
Published on 06/17/2026 at 00:00, 6 hours 45 minutes ago Onco-Innovations Completes Project with Kuano, Using Their Quantum-Based Platform to Deliver Insights for PNKP Inhibitor Technology Optimization
Published on 06/16/2026 at 23:10, 7 hours 35 minutes ago Crestone Air Partners, an Air T Business, Completes Acquisition of Arena Aviation Capital, Surpassing $3.6 Billion in Assets Under Management
Published on 06/17/2026 at 05:35, 1 hour 10 minutes ago How to Build a Plug-in Balcony Solar System with Your Existing Portable Power Station
Published on 06/17/2026 at 04:15, 2 hours 30 minutes ago Frost & Sullivan White Paper Names Phancy Rise vGPU a Tier 1 Leading Platform
Published on 06/16/2026 at 19:05, 11 hours 40 minutes ago AT&S announces the Reference Share Price and the Conversion Price of the new deeply subordinated perpetual convertible bond with an early redemption option for the Company
Published on 06/16/2026 at 19:00, 11 hours 45 minutes ago R. STAHL Shareholders approve nearly all agenda items at the Annual General Meeting – Executive Board confirms annual forecast
Published on 06/16/2026 at 11:44, 19 hours 1 minute ago Guillemot Corporation S.A. | Weekly report share buyback from June 8 to June 12 2026
Published on 06/15/2026 at 23:00, 1 day 7 hours ago BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES
Published on 06/15/2026 at 18:57, 1 day 11 hours ago Reporting on share buyback transactions carried out between June 8 and June 11, 2026
Published on 06/15/2026 at 18:32, 1 day 12 hours ago Edenred strengthens its electric charging offering with the acquisition of The Mobility House Solutions
Published on 06/15/2026 at 18:30, 1 day 12 hours ago Increase in the resources allocated to the liquidity contract with ODDO BHF
